GO:0043176 amine binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043176 amine binding is a molecular function defined as binding to an amine, a weakly basic organic compound containing an amino or substituted amino group.
• Amine binding is central to enzyme catalysis, receptor signaling, and drug action, as shown for carbonic anhydrases, trace amine receptors, and amine transaminases.
• Key proteins include carbonic anhydrases, TAAR1, yellow-related salivary proteins, and ω-amine transaminases, which use amine binding for substrate recognition or activation.
• Amine-reactive probes and amine-functionalized nanoparticles exploit amine binding for labeling and delivery applications.
• Dysregulated amine binding contributes to neurological disorders, cancer, and metabolic diseases, making it a target for therapeutic intervention.
• CRISPR-based knockout, knock-in, and point-mutation models enable causal testing of amine-binding proteins in disease and drug response.
Description
Amine binding (GO:0043176) is a molecular function that describes the selective interaction of a protein or molecule with an amine, a weakly basic organic compound containing an amino or substituted amino group. This function is fundamental to many biological processes, including neurotransmitter signaling, enzyme catalysis, and drug metabolism. For researchers, understanding amine binding is critical because it underlies the specificity of numerous therapeutic targets and diagnostic tools. Amine-binding proteins are involved in diverse physiological roles, from carbonic anhydrase activation by amines and amino acids to the recognition of trace amines by G-protein-coupled receptors. In drug discovery, amine-reactive probes and amine-functionalized nanoparticles are engineered to exploit this binding for covalent labeling and targeted delivery. Moreover, amine binding influences the pharmacokinetics of basic drugs through interactions with phosphatidylserine, affecting tissue distribution. Given its broad impact, amine binding is a key area of study in molecular biology, pharmacology, and biotechnology.
amine binding At A Glance
| GO ID | GO:0043176 |
|---|---|
| GO term | amine binding |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Binding to an amine, a weakly basic organic compound that contains an amino or a substituted amino group. |
| Major function | Selective interaction with amines for catalysis, signaling, or transport |
| Examples | Carbonic anhydrases, trace amine receptor TAAR1, amine transaminases, yellow-related proteins |
| Related diseases | Neurological disorders, cancer, metabolic diseases |
What Is GO:0043176?
According to the Gene Ontology, amine binding (GO:0043176) is the molecular function of binding to an amine, which is a weakly basic organic compound that contains an amino group or a substituted amino group. This definition encompasses non-covalent and covalent interactions with primary, secondary, or tertiary amines, as well as amino acids and amine-containing drugs. The term is used to annotate gene products that selectively recognize and bind such compounds, often as part of enzymatic reactions, receptor-ligand interactions, or transport processes.
Why Is amine binding Important in Cell Biology?
Amine binding is essential for numerous biological and pharmacological processes. It governs the activity of enzymes such as carbonic anhydrases, which are activated by amines and amino acids and are targets for drugs against glaucoma and cancer. In the nervous system, amine binding to receptors like TAAR1 modulates neurotransmission and is implicated in schizophrenia and addiction. Amine-binding proteins in insects, such as yellow-related proteins, facilitate blood feeding and pathogen transmission. Biotechnologically, engineered amine transaminases with altered amine binding are used for chiral amine synthesis. Additionally, amine-reactive probes and nanoparticles are valuable tools for chemical biology and nanomedicine. Thus, studying amine binding advances both basic science and translational applications.
• Enables selective drug action on carbonic anhydrases for glaucoma and cancer therapy.
• Mediates trace amine signaling in the brain, relevant to psychiatric disorders.
• Facilitates blood feeding in sand flies and Leishmania transmission.
• Supports biocatalytic synthesis of chiral amines for pharmaceuticals.
• Provides chemical tools for covalent labeling and imaging.
• Influences tissue distribution of basic drugs via phosphatidylserine binding.
• Enables fluorescent labeling and sensing with amine-functionalized quantum dots.
• Serves as a model for studying substrate recognition and enzyme evolution.
• Contributes to host-pathogen interactions in vector-borne diseases.
• Offers targets for designing new therapeutics and diagnostics.
Molecular Mechanism of amine binding
Substrate Recognition and Binding Site Architecture
In simple terms: Proteins have specially shaped pockets that grab onto amines.
Amine-binding proteins typically possess a binding pocket with acidic or polar residues that interact with the amino group of the amine. For example, carbonic anhydrases bind amines and amino acids through coordination to the zinc ion and hydrogen bonding with hydrophilic residues, as revealed by binding site comparisons. The trace amine receptor TAAR1 recognizes amines via a conserved aspartate residue in the third transmembrane helix, which forms an ionic interaction with the protonated amine. In sand fly yellow-related proteins, amine binding involves a hydrophobic cleft that accommodates the amine moiety. These structural features ensure specificity and affinity.
Catalytic Mechanisms Involving Amine Binding
In simple terms: Some enzymes use amine binding to speed up chemical reactions.
In enzymes like ω-amine transaminases, amine binding is part of the catalytic cycle: the amine substrate forms a Schiff base with the pyridoxal 5'-phosphate (PLP) cofactor, facilitating transfer of the amino group. Carbonic anhydrase activation by amines involves binding near the active site, which modulates the pKa of the zinc-bound water and enhances catalytic turnover. These mechanisms are exploited in biocatalysis for the synthesis of chiral amines.
Cofactors and Regulatory Ions
In simple terms: Metal ions and cofactors help proteins bind amines correctly.
Many amine-binding proteins require metal ions or organic cofactors. Carbonic anhydrases depend on a zinc ion for catalysis and amine binding. ω-Amine transaminases require PLP as a cofactor, which forms a covalent adduct with the amine substrate. In TAAR1, no metal cofactor is known, but G-protein coupling is regulated by amine binding. These cofactors fine-tune the binding affinity and reactivity.
Regulation of Amine Binding
In simple terms: Cells can turn amine binding on or off to control processes.
Amine binding can be regulated by post-translational modifications, allosteric interactions, or changes in local pH. For instance, the binding of amines to carbonic anhydrases is pH-dependent due to the protonation state of the amine. In TAAR1, agonist binding is modulated by receptor phosphorylation and arrestin recruitment. Additionally, amine-functionalized nanoparticles can be designed to release bound amines in response to stimuli. Such regulation ensures precise control of biological functions.
Key Genes Involved in GO:0043176 amine binding
The following genes and proteins are representative examples of amine-binding molecules, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CA2 | Carbonic anhydrase II; binds amines and amino acids | Drug target for glaucoma and cancer |
| CA9 | Carbonic anhydrase IX; binds amines | Cancer biomarker and therapeutic target |
| TAAR1 | Trace amine receptor; binds amines | Neurological and psychiatric disorders |
| TAAR2 | Trace amine receptor; binds amines | Olfactory and neurological functions |
| TAAR5 | Trace amine receptor; binds amines | Behavior and mood regulation |
| Yellow-related protein | Salivary protein; binds amines | Vector-host interaction |
| AtATA | ω-Amine transaminase; binds amines | Biocatalysis for chiral amines |
| HSA | Human serum albumin; binds amine-containing compounds | Drug transport and delivery |
| PS | Phosphatidylserine; binds amine-containing basic compounds | Drug distribution |
| Carbon quantum dots | Amine-functionalized nanoparticles; bind amines | Fluorescent labeling |
| MAO-A | Monoamine oxidase A; binds amines | Neurotransmitter metabolism |
| MAO-B | Monoamine oxidase B; binds amines | Neurodegeneration |
| DAT | Dopamine transporter; binds amines | Addiction and ADHD |
| SERT | Serotonin transporter; binds amines | Depression and anxiety |
| NET | Norepinephrine transporter; binds amines | Cardiovascular and psychiatric disorders |
| COMT | Catechol-O-methyltransferase; binds amines | Schizophrenia and pain |
| AANAT | Aralkylamine N-acetyltransferase; binds amines | Melatonin synthesis |
How Is amine binding Regulated?
Amine binding is regulated at multiple levels. The protonation state of the amine, influenced by local pH, determines its ability to form ionic interactions with binding pockets. In enzymes like carbonic anhydrases, binding of amines can be allosterically modulated by other ligands or by changes in zinc coordination. For G-protein-coupled receptors such as TAAR1, agonist binding is regulated by receptor phosphorylation, desensitization, and internalization. Additionally, the expression levels of amine-binding proteins are controlled transcriptionally and post-translationally, affecting overall binding capacity. In biotechnology, amine-functionalized surfaces can be engineered to control binding affinity and specificity.
amine binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CA2 | Glaucoma, cancer | Knockout mice, point mutation of zinc-binding site |
| TAAR1 | Schizophrenia, addiction | Knockout rats, humanized knock-in mice |
| MAO-A | Depression, aggression | Knockout mice, point mutation of active site |
| DAT | ADHD, addiction | Knockout mice, overexpression in cell lines |
| Yellow-related protein | Leishmania transmission | Knockdown in sand flies, recombinant protein binding assays |
Amine Binding in Neurological and Psychiatric Disorders
Trace amine-associated receptor 1 (TAAR1) binds endogenous amines such as tyramine and β-phenylethylamine, and its dysfunction is implicated in schizophrenia, bipolar disorder, and addiction. Monoamine transporters and enzymes that bind amines are targets for antidepressants and stimulants. Thus, altered amine binding can lead to neurotransmitter imbalances and psychiatric symptoms.
Amine Binding in Cancer
Carbonic anhydrases, which bind amines and amino acids, are overexpressed in many tumors and contribute to pH regulation and metastasis. Inhibitors that block amine binding to carbonic anhydrases are being developed as anticancer agents. Additionally, amine-functionalized nanoparticles are explored for targeted drug delivery to tumors.
Amine Binding in Infectious Diseases
Salivary yellow-related proteins from sand flies bind amines, which may facilitate blood feeding and Leishmania transmission. Understanding these interactions could inform vector control strategies. In addition, amine-binding properties of host proteins like phosphatidylserine influence the distribution of basic drugs used against infections.
From amine binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of amine binding affect enzyme activity? | Knockout cell line or animal |
| How does a point mutation alter substrate specificity? | Point mutation knock-in via CRISPR |
| Can a tagged amine-binding protein be tracked in live cells? | Tagged knock-in (e.g., GFP) |
| What is the effect of overexpression on signaling? | Overexpression cell line |
| Which genes regulate amine binding in a pathway? | CRISPR library screening |
| How does amine binding change in disease states? | Patient-derived organoids with CRISPR editing |
How to Study the amine binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry | Binding affinity and thermodynamics | Characterize amine binding to enzymes |
| Surface plasmon resonance | Kinetics of binding | Screen amine analogs |
| X-ray crystallography | 3D structure of binding site | Structure-based drug design |
| Cryo-EM | Structure of membrane receptors | GPCR-amine complexes |
| CRISPR knockout screening | Gene essentiality for amine binding | Identify novel regulators |
| Fluorescence microscopy | Cellular localization of amine probes | Imaging amine uptake |
| Mass spectrometry | Identification of amine-bound proteins | Proteomics of amine interactome |
Binding Assays
Equilibrium dialysis, isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR) are used to measure amine binding affinity and kinetics. These methods provide quantitative data on dissociation constants and stoichiometry.
Structural Biology
X-ray crystallography and cryo-electron microscopy reveal the atomic details of amine binding pockets, as demonstrated for TAAR1 and carbonic anhydrases. These structures guide drug design and mutagenesis studies.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate amine binding or sensitivity to amine-containing drugs. This approach is powerful for discovering novel components of amine-binding pathways.
Fluorescent Labeling and Imaging
Amine-reactive probes and amine-functionalized quantum dots enable visualization of amine binding in cells and tissues. These tools are useful for tracking localization and dynamics.
How CRISPR Can Be Used to Study GO:0043176 amine binding
Knockout
CRISPR knockout of genes encoding amine-binding proteins (e.g., CA2, TAAR1) can abolish binding and reveal loss-of-function phenotypes in cell models and animals. This approach is essential for validating target function.
Point Mutation
Introducing point mutations in the amine-binding pocket (e.g., aspartate to alanine in TAAR1) via CRISPR base editing or HDR can dissect the contribution of specific residues to binding affinity and specificity.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA) of amine-binding proteins allows real-time tracking and interactome analysis without altering endogenous regulation. This is valuable for studying dynamic binding events.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase levels of amine-binding proteins to study gain-of-function effects, such as enhanced signaling or drug sensitivity.
How EDITGENE Supports amine binding Research
Researchers studying amine binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models, enabling rigorous functional validation of amine-binding proteins and their regulators.
Contact EDITGENE today to design your custom CRISPR model for amine binding research.
Frequently Asked Questions About amine binding
What is amine binding?
Amine binding (GO:0043176) is a molecular function where a protein or molecule selectively interacts with an amine, a weakly basic organic compound containing an amino or substituted amino group.
What genes are involved in amine binding?
Genes such as CA2, CA9, TAAR1, MAO-A, MAO-B, DAT, SERT, and COMT encode proteins that bind amines.
How is amine binding studied?
Common methods include isothermal titration calorimetry, surface plasmon resonance, X-ray crystallography, and CRISPR screening.
What diseases are linked to amine binding?
Amine binding is implicated in neurological disorders, cancer, and infectious diseases.
What is the GO term for amine binding?
The Gene Ontology term for amine binding is GO:0043176, under the molecular_function ontology.
Can CRISPR be used to study amine binding?
Yes, CRISPR knockout, knock-in, and point mutation models allow functional dissection of amine-binding proteins.
What are amine-reactive probes?
Amine-reactive probes are chemical tools that covalently label amines, used for detection and imaging.
How do amine transaminases use amine binding?
ω-Amine transaminases bind amines via a PLP cofactor to catalyze transfer of amino groups, important for chiral amine synthesis.
What is the role of TAAR1 in amine binding?
TAAR1 is a G-protein-coupled receptor that binds trace amines and regulates neurotransmission, with implications for psychiatric disorders.
How does phosphatidylserine bind amines?
Phosphatidylserine binds amine-containing basic compounds, influencing their tissue distribution.
Conclusion
Amine binding (GO:0043176) is a fundamental molecular function with broad relevance in enzymology, neurobiology, and drug discovery. The diverse proteins that bind amines, from carbonic anhydrases to trace amine receptors, underscore its importance in health and disease. Advances in CRISPR genome editing and chemical biology continue to illuminate the mechanisms and therapeutic potential of amine binding. EDITGENE's comprehensive CRISPR services empower researchers to explore this function with precision and scale.
References
- 1. Petreni A et al.. 2021. Binding site comparison for coumarin inhibitors and amine/amino acid activators of human carbonic anhydrases.. Eur J Med Chem 226:113875 PMID: 34634741
- 2. Xu Z et al.. 2023. Ligand recognition and G-protein coupling of trace amine receptor TAAR1.. Nature 624(7992):672-681 PMID: 37935376
- 3. Sumova P et al.. 2019. Amine-binding properties of salivary yellow-related proteins in phlebotomine sand flies.. Insect Biochem Mol Biol 115:103245 PMID: 31604119
- 4. Qiu S et al.. 2024. Evolving ω-amine transaminase AtATA guided by substrate-enzyme binding free energy for enhancing activity and stability against non-natural substrates.. Appl Environ Microbiol 90(7):e0054324 PMID: 38864627
- 5. Taylor KI et al.. 2023. Assessing Squarates as Amine-Reactive Probes.. J Am Chem Soc 145(46):25056-25060 PMID: 37938802
- 6. Jain A et al.. 2024. Supported-amine-catalyzed cascade synthesis of spiro-thiazolone-tetrahydrothiophenes: assessing HSA binding activity.. Org Biomol Chem 22(25):5087-5092 PMID: 38835316
- 7. Murakami T et al.. 2011. Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds.. Expert Opin Drug Metab Toxicol 7(3):353-64 PMID: 21332386
- 8. Lisa John V et al.. 2022. Amine functionalized carbon quantum dots from paper precursors for selective binding and fluorescent labelling applications.. J Colloid Interface Sci 617:730-744 PMID: 35316786
